Sodium-Glucose Cotransporter Inhibitors and Clinical Outcomes in Hypertrophic Cardiomyopathy, A Retrospective Cohort Study

Key Points

• Clinical outcomes improve in hypertrophic cardiomyopathy with sodium-glucose cotransporter inhibitors, indicating therapeutic potential.
• A relevant metric shows a significant improvement in patient symptoms and overall heart function.
• Retrospective cohort analysis evaluates the effectiveness of sodium-glucose cotransporter inhibitors in a specific population over time.
• This study highlights a potential new treatment pathway for hypertrophic cardiomyopathy, but more research is needed for broader applicability.